Literature DB >> 3160313

Sclerosing cholangitis after continuous hepatic artery infusion of FUDR.

M M Kemeny, H Battifora, D W Blayney, G Cecchi, D A Goldberg, L A Leong, K A Margolin, J J Terz.   

Abstract

Eight of 46 (17.4%) patients treated in our trial of continuous hepatic artery infusion (CHAI) of fluorodeoxyuridine (FUDR) by Infusaid pump developed biliary strictures. The lesions were clinically, radiographically, and pathologically identical to the idiopathic sclerosing cholangitis frequently seen in association with inflammatory bowel disease. Treatment included immediate cessation of intraarterial FUDR, and surgical or percutaneous drainage of the biliary tree if it was dilated. Two of the eight patients died of the complication. Three patients stabilized after biliary system drainage, and two patients improved on observation only. The pathogenesis of this complication is not understood. This report details the clinical and pathological features of this entity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3160313      PMCID: PMC1250871          DOI: 10.1097/00000658-198508000-00007

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  5 in total

1.  Intrahepatic arterial infusion with 5-fluorouracil.

Authors:  F J Ansfield; G Ramirez; J L Skibba; G T Bryan; H L Davis; G W Wirtanen
Journal:  Cancer       Date:  1971-11       Impact factor: 6.860

2.  Continuous regional chemotherapy for metastatic colorectal cancer using a totally implantable infusion pump. A feasibility study in 50 patients.

Authors:  C M Balch; M M Urist; M L McGregor
Journal:  Am J Surg       Date:  1983-02       Impact factor: 2.565

3.  Experience with continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries. A prospective randomized study.

Authors:  M M Kemeny; D A Goldberg; S Browning; G E Metter; P J Miner; J J Terz
Journal:  Cancer       Date:  1985-03-15       Impact factor: 6.860

4.  Sclerosing cholangitis. Anatomical distribution of obstructive lesions.

Authors:  J L Cameron; B W Gayler; H Sanfey; F Milligan; S Kaufman; W C Maddrey; H F Herlong
Journal:  Ann Surg       Date:  1984-07       Impact factor: 12.969

5.  A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump.

Authors:  C M Balch; M M Urist; S J Soong; M McGregor
Journal:  Ann Surg       Date:  1983-11       Impact factor: 12.969

  5 in total
  25 in total

1.  Hepatic artery infusion as treatment of hepatic metastases from colorectal cancer.

Authors:  M M Kemeny
Journal:  J Gastrointest Surg       Date:  1997 Sep-Oct       Impact factor: 3.452

Review 2.  Continuous hepatic artery infusion (CHAI) as treatment of liver metastases. Are the complications worth it?

Authors:  M M Kemeny
Journal:  Drug Saf       Date:  1991 May-Jun       Impact factor: 5.606

3.  Percutaneous hepatic venous isolation and extracorporeal charcoal hemoperfusion for high-dose intraarterial chemotherapy in patients with colorectal hepatic metastases.

Authors:  Y Ku; M Tominaga; T Iwasaki; T Kitagawa; I Maeda; M Shiotani; S Kusunoki; Y Maekawa; M Samizo; T Fukumoto; Y Kuroda; S Hirota; Y Saitoh
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

Review 4.  The current diagnosis and treatment of benign biliary stricture.

Authors:  Hiroshi Shimada; Itaru Endo; Kazuhiro Shimada; Ryusei Matsuyama; Noritoshi Kobayashi; Kensuke Kubota
Journal:  Surg Today       Date:  2012-09-22       Impact factor: 2.549

Review 5.  Hepatic arterial infusional chemotherapy in the management of colorectal cancer liver metastases.

Authors:  Alexandre Doussot; Nancy E Kemeny; Michael I D'Angelica
Journal:  Hepat Oncol       Date:  2015-07-27

6.  A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases.

Authors:  A E Chang; P D Schneider; P H Sugarbaker; C Simpson; M Culnane; S M Steinberg
Journal:  Ann Surg       Date:  1987-12       Impact factor: 12.969

7.  Regional infusion of fluoropyrimidines for hepatic metastases of colorectal cancer.

Authors:  C H Koks; J R Brouwers; D T Sleijfer
Journal:  Pharm Weekbl Sci       Date:  1988-04-22

8.  Regional and systemic chemotherapy for colorectal metastases to the liver.

Authors:  C M Balch; B Levin
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

9.  Chemotherapy-induced sclerosing cholangitis as a rare indication for resection: report of a case.

Authors:  Yutaro Kato; Kentaro Matsubara; Yoshinobu Akiyama; Hiroaki Hattori; Akira Hirata; Fumio Suzuki; Hitoshi Ohtaka; Ayu Kato; Yoshiaki Sugiura; Masaki Kitajima
Journal:  Surg Today       Date:  2009-09-27       Impact factor: 2.549

Review 10.  Drug-induced cholestasis.

Authors:  H J Zimmerman; J H Lewis
Journal:  Med Toxicol       Date:  1987 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.